Commercial Physical & Biological Research Industry - SEC Form 4 Insider Trading Screener
Services Sector - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2020-01-23 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $19.41 | -25,000 | 425,840 | -6% | -$485,250 | |||||
2020-01-22 | EXEL | Exelixis, Inc. | Scangos George A | Dir | S - Sale | $19.75 | -25,000 | 1,061,626 | -2% | -$493,750 | ||||||
| A | 2019-10-04 | NRC | National Research Corp | Jackson Steven D. | Pres | S - Sale | $59.15 | -4,010 | 89,586 | -4% | -$237,195 | |||||
| M | 2020-01-22 | NRC | National Research Corp | Amandla Mk Trust | 10% | S - Sale | $70.07 | -7,830 | 6,484,751 | 0% | -$548,660 | |||||
| D | 2020-01-17 | IQV | Iqvia Holdings Inc. | Evanisko Michael J | Dir | S - Sale+OE | $160.76 | -6,250 | 5,250 | -54% | -$1,004,750 | |||||
2020-01-15 | EXEL | Exelixis, Inc. | Marchesi Vincent T | Dir | S - Sale | $20.01 | -61,683 | 82,484 | -43% | -$1,234,277 | ||||||
| D | 2020-01-16 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $20.33 | -25,000 | 425,840 | -6% | -$508,250 | |||||
2020-01-15 | EXEL | Exelixis, Inc. | Scangos George A | Dir | S - Sale | $20.39 | -25,000 | 1,086,626 | -2% | -$509,750 | ||||||
2020-01-16 | EXAS | Exact Sciences Corp | Cole G Bradley | GM - Diagnostics | S - Sale | $90.30 | -10,000 | 20,987 | -32% | -$903,000 | ||||||
| D | 2020-01-15 | INCY | Incyte Corp | Swain Paula J | EVP, HR | S - Sale+OE | $81.12 | -2,500 | 41,612 | -6% | -$202,800 | |||||
| D | 2020-01-10 | IQV | Iqvia Holdings Inc. | Evanisko Michael J | Dir | S - Sale+OE | $160.08 | -6,250 | 5,250 | -54% | -$1,000,500 | |||||
2020-01-10 | NRC | National Research Corp | Amandla Mk Trust | 10% | S - Sale | $68.00 | -200 | 6,492,581 | 0% | -$13,600 | ||||||
| M | 2020-01-08 | NRC | National Research Corp | Amandla Mk Trust | 10% | S - Sale | $68.13 | -6,276 | 6,492,781 | 0% | -$427,563 | |||||
| D | 2020-01-08 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $18.85 | -25,000 | 425,840 | -6% | -$471,250 | |||||
| D | 2020-01-07 | EXEL | Exelixis, Inc. | Garber Alan M | Dir | S - Sale+OE | $18.01 | -86,956 | 61,329 | -59% | -$1,566,078 | |||||
| D | 2020-01-07 | EXEL | Exelixis, Inc. | Schwab Gisela | Pres, Prod Dev, Med Aff, CMO | S - Sale+OE | $17.96 | -50,000 | 340,002 | -13% | -$898,000 | |||||
| M | 2020-01-06 | NRC | National Research Corp | Amandla Mk Trust | 10% | S - Sale | $68.30 | -8,622 | 6,499,057 | 0% | -$588,850 | |||||
| D | 2020-01-06 | XON | Intrexon Corp | Bostick Thomas | COO | S - Sale+OE | $5.83 | -6,533 | 74,280 | -8% | -$38,083 | |||||
| D | 2020-01-06 | XON | Intrexon Corp | Lehr Donald P. | GC | S - Sale+OE | $5.83 | -7,155 | 93,991 | -7% | -$41,708 | |||||
| D | 2020-01-06 | XON | Intrexon Corp | Perez Jeffrey Thomas | SVP, IP Affairs | S - Sale+OE | $5.83 | -6,533 | 80,948 | -7% | -$38,083 | |||||
| D | 2020-01-06 | XON | Intrexon Corp | Reed Thomas D. | Chief Science Officer | S - Sale+OE | $5.83 | -5,416 | 255,873 | -2% | -$31,571 | |||||
| D | 2020-01-06 | XON | Intrexon Corp | Sabzevari Helen | Pres, CEO | S - Sale+OE | $5.83 | -6,732 | 98,002 | -6% | -$39,243 | |||||
| D | 2020-01-06 | XON | Intrexon Corp | Sterling Rick L. | CFO | S - Sale+OE | $5.83 | -6,533 | 143,032 | -4% | -$38,082 | |||||
2020-01-02 | IQV | Iqvia Holdings Inc. | McDonnell Michael R | EVP, CFO | S - Sale | $155.07 | -12,000 | 14,366 | -46% | -$1,860,840 | ||||||
| D | 2020-01-03 | XON | Intrexon Corp | Sterling Rick L. | CFO | S - Sale+OE | $5.77 | -3,564 | 130,625 | -3% | -$20,564 | |||||
| D | 2020-01-03 | XON | Intrexon Corp | Sabzevari Helen | Pres, CEO | S - Sale+OE | $5.77 | -3,886 | 87,067 | -4% | -$22,421 | |||||
| D | 2020-01-03 | XON | Intrexon Corp | Reed Thomas D. | Chief Science Officer | S - Sale+OE | $5.77 | -2,986 | 242,349 | -1% | -$17,229 | |||||
| D | 2020-01-03 | XON | Intrexon Corp | Bostick Thomas | COO | S - Sale+OE | $5.77 | -3,564 | 61,873 | -5% | -$20,564 | |||||
| D | 2020-01-03 | XON | Intrexon Corp | Lehr Donald P. | GC | S - Sale+OE | $5.77 | -3,886 | 82,206 | -5% | -$22,422 | |||||
| D | 2020-01-03 | XON | Intrexon Corp | Perez Jeffrey Thomas | SVP, IP Affairs | S - Sale+OE | $5.77 | -3,564 | 68,541 | -5% | -$20,564 | |||||
| M | 2019-12-02 | BUDZ | Weed, Inc. | Kwestel Elliot | Director of WEED Israel Ltd. | S - Sale | $0.34 | -59,000 | 0 | -100% | -$20,283 | |||||
| M | 2019-11-01 | BUDZ | Weed, Inc. | Kwestel Elliot | Director of WEED Israel Ltd. | S - Sale | $0.39 | -29,950 | 128,000 | -19% | -$11,768 | |||||
| M | 2019-08-08 | BUDZ | Weed, Inc. | Kwestel Elliot | Director of WEED Israel Ltd. | S - Sale | $0.43 | -29,050 | 88,950 | -25% | -$12,460 | |||||
| D | 2020-01-02 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $17.49 | -25,000 | 425,840 | -6% | -$437,250 | |||||
| D | 2020-01-02 | XON | Intrexon Corp | Sterling Rick L. | CFO | S - Sale+OE | $5.60 | -4,366 | 124,423 | -3% | -$24,450 | |||||
| D | 2020-01-02 | XON | Intrexon Corp | Sabzevari Helen | Pres, CEO | S - Sale+OE | $5.60 | -4,830 | 81,187 | -6% | -$27,048 | |||||
| D | 2020-01-02 | XON | Intrexon Corp | Reed Thomas D. | Chief Science Officer | S - Sale+OE | $5.60 | -3,533 | 235,569 | -1% | -$19,785 | |||||
| D | 2020-01-02 | XON | Intrexon Corp | Perez Jeffrey Thomas | SVP, IP Affairs | S - Sale+OE | $5.60 | -4,366 | 62,339 | -7% | -$24,450 | |||||
| D | 2020-01-02 | XON | Intrexon Corp | Lehr Donald P. | GC | S - Sale+OE | $5.60 | -4,830 | 76,326 | -6% | -$27,048 | |||||
| D | 2020-01-02 | XON | Intrexon Corp | Bostick Thomas | COO | S - Sale+OE | $5.60 | -4,366 | 55,671 | -7% | -$24,450 | |||||
2019-12-27 | EXEL | Exelixis, Inc. | Scangos George A | Dir | S - Sale | $18.25 | -25,000 | 1,114,126 | -2% | -$456,250 | ||||||
2019-12-23 | NRC | National Research Corp | Amandla Mk Trust | 10% | S - Sale | $68.05 | -10,000 | 6,507,679 | 0% | -$680,525 | ||||||
| D | 2019-12-20 | IQV | Iqvia Holdings Inc. | Leonard John M. | Dir | S - Sale+OE | $153.00 | -20,200 | 8,252 | -71% | -$3,090,600 | |||||
| M | 2019-12-19 | MEDP | Medpace Holdings, Inc. | Geiger Jesse J | CFO, COO, Lab Operations | S - Sale | $83.08 | -31,348 | 0 | -100% | -$2,604,432 | |||||
| D | 2019-12-16 | INCY | Incyte Corp | Swain Paula J | EVP, HR | S - Sale+OE | $91.61 | -2,500 | 41,612 | -6% | -$229,025 | |||||
| D | 2019-12-09 | CRL | Charles River Laboratories International, Inc. | Johst David P | Corporate EVP | S - Sale+OE | $144.22 | -24,660 | 212,854 | -10% | -$3,556,341 | |||||
2019-12-09 | CRL | Charles River Laboratories International, Inc. | Girshick Birgit | Corporate EVP | S - Sale | $145.55 | -1,051 | 17,715 | -6% | -$152,972 | ||||||
2019-12-09 | CRL | Charles River Laboratories International, Inc. | Girshick Birgit | Corporate EVP | S - Sale | $144.93 | -2,874 | 18,766 | -13% | -$416,516 | ||||||
2019-12-09 | CRL | Charles River Laboratories International, Inc. | Girshick Birgit | Corporate EVP | S - Sale | $144.21 | -2,420 | 21,640 | -10% | -$348,993 | ||||||
| D | 2019-12-03 | EXEL | Exelixis, Inc. | Schwab Gisela | Pres, Prod Dev, Med Aff, CMO | S - Sale+OE | $16.22 | -50,000 | 328,437 | -13% | -$811,000 | |||||
2019-12-02 | NRC | National Research Corp | Amandla Mk Trust | 10% | S - Sale | $63.94 | -1,400 | 6,517,679 | 0% | -$89,514 | ||||||
| DM | 2019-11-29 | INCY | Incyte Corp | Wenqing Yao | EVP, Head of Discovery Chem | S - Sale+OE | $95.00 | -20,000 | 95,308 | -17% | -$1,900,000 | |||||
| DM | 2019-11-29 | INCY | Incyte Corp | Iyengar Vijay K | EVP GPS, BD, Licensing | S - Sale+OE | $95.00 | -7,866 | 17,609 | -31% | -$747,270 | |||||
| DM | 2019-11-29 | INCY | Incyte Corp | Flannelly Barry P | EVP, GM US | S - Sale+OE | $95.00 | -7,182 | 16,979 | -30% | -$682,290 | |||||
2019-12-02 | INTI | Inhibitor Therapeutics, Inc. | Hasara Garrison J. | CFO, Treasurer | P - Purchase | $0.07 | +13,500 | 3,972,544 | 0% | +$945 | ||||||
| M | 2019-11-27 | NRC | National Research Corp | Amandla Mk Trust | 10% | S - Sale | $63.98 | -7,453 | 6,519,079 | 0% | -$476,850 | |||||
| M | 2019-10-28 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.40 | -66,000 | 23,563,421 | 0% | -$26,280 | |||||
| M | 2019-10-09 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.40 | -64,580 | 23,629,421 | 0% | -$25,712 | |||||
| M | 2019-11-25 | NRC | National Research Corp | Amandla Mk Trust | 10% | S - Sale | $63.98 | -5,941 | 6,526,532 | 0% | -$380,103 | |||||
| D | 2019-11-25 | INCY | Incyte Corp | Flannelly Barry P | EVP, GM US | S - Sale+OE | $90.00 | -2,142 | 16,979 | -11% | -$192,780 | |||||
| D | 2019-11-25 | INCY | Incyte Corp | Wenqing Yao | EVP, Head of Discovery Chem | S - Sale+OE | $90.00 | -15,000 | 95,308 | -14% | -$1,350,000 | |||||
| D | 2019-11-25 | INCY | Incyte Corp | Trower Paul | Principal Accounting Officer | S - Sale+OE | $90.00 | -15,000 | 17,306 | -46% | -$1,350,000 | |||||
2019-11-21 | EXAS | Exact Sciences Corp | Cole G Bradley | GM - Diagnostics | S - Sale | $80.38 | -28,016 | 43,321 | -39% | -$2,251,926 | ||||||
| M | 2019-11-21 | NRC | National Research Corp | Amandla Mk Trust | 10% | S - Sale | $63.87 | -1,800 | 6,532,473 | 0% | -$114,970 | |||||
| M | 2019-11-19 | NRC | National Research Corp | Mowry Barbara | Dir | S - Sale | $62.49 | -14,785 | 6,902 | -68% | -$923,871 | |||||
| D | 2019-11-15 | INCY | Incyte Corp | Swain Paula J | EVP, HR | S - Sale+OE | $86.46 | -2,500 | 41,612 | -6% | -$216,150 | |||||
| M | 2019-11-15 | NRC | National Research Corp | Mowry Barbara | Dir | S - Sale | $61.86 | -3,215 | 21,687 | -13% | -$198,865 | |||||
| M | 2019-11-13 | NRC | National Research Corp | Mowry Barbara | Dir | S - Sale | $61.73 | -7,762 | 24,902 | -24% | -$479,158 | |||||
2019-11-13 | CRL | Charles River Laboratories International, Inc. | Girshick Birgit | Corporate EVP | S - Sale | $137.23 | -1,499 | 24,060 | -6% | -$205,712 | ||||||
| D | 2019-11-13 | CRL | Charles River Laboratories International, Inc. | Girshick Birgit | Corporate EVP | S - Sale+OE | $137.04 | -8,105 | 25,559 | -24% | -$1,110,717 | |||||
2019-11-08 | GHDX | Genomic Health Inc | Exact Sciences Corp | See Footnotes, 10% | P - Purchase | $0.00 | +37,643,330 | 100 | -100% | +$0 | ||||||
| DM | 2019-11-06 | INCY | Incyte Corp | Dixon Wendy L | Dir | S - Sale+OE | $83.92 | -53,334 | 12,340 | -81% | -$4,475,774 | |||||
| D | 2019-11-04 | EXEL | Exelixis, Inc. | Schwab Gisela | Pres, Prod Dev, Med Aff, CMO | S - Sale+OE | $15.99 | -50,000 | 339,211 | -13% | -$799,500 | |||||
| D | 2019-11-01 | INCY | Incyte Corp | Wenqing Yao | EVP, Head of Discovery Chem | S - Sale+OE | $85.00 | -7,960 | 95,308 | -8% | -$676,600 | |||||
| D | 2019-11-01 | INCY | Incyte Corp | Trower Paul | Principal Accounting Officer | S - Sale+OE | $85.00 | -8,500 | 17,306 | -33% | -$722,500 | |||||
| D | 2019-10-29 | INCY | Incyte Corp | Wenqing Yao | EVP, Head of Discovery Chem | S - Sale+OE | $85.00 | -2,040 | 95,308 | -2% | -$173,400 | |||||
| D | 2019-10-29 | INCY | Incyte Corp | Trower Paul | Principal Accounting Officer | S - Sale+OE | $80.45 | -16,500 | 17,306 | -49% | -$1,327,500 | |||||
2019-10-29 | INCY | Incyte Corp | Iyengar Vijay K | EVP GPS, BD, Licensing | S - Sale | $85.00 | -930 | 17,609 | -5% | -$79,050 | ||||||
| D | 2019-10-22 | INCY | Incyte Corp | Swain Paula J | EVP, HR | S - Sale+OE | $80.00 | -2,500 | 41,612 | -6% | -$200,000 | |||||
2019-10-18 | MEDP | Medpace Holdings, Inc. | Ewald Stephen P | GC, Corp. Secy. | S - Sale | $77.30 | -8,000 | 0 | -100% | -$618,400 | ||||||
| M | 2019-10-14 | MEDP | Medpace Holdings, Inc. | Geiger Jesse J | CFO, COO, Lab Operations | S - Sale | $79.16 | -16,800 | 31,348 | -35% | -$1,329,816 | |||||
2019-10-10 | EXEL | Exelixis, Inc. | Haley Patrick J. | SVP, Commercial | S - Sale | $16.27 | -303 | 123,396 | 0% | -$4,930 | ||||||
| M | 2019-09-19 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.41 | -65,334 | 23,694,001 | 0% | -$26,460 | |||||
| M | 2019-09-11 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.45 | -29,604 | 23,759,345 | 0% | -$13,453 | |||||
| M | 2019-08-30 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.41 | -46,000 | 23,788,949 | 0% | -$18,875 | |||||
| D | 2019-09-25 | NRC | National Research Corp | Jackson Steven D. | Pres | S - Sale+OE | $59.15 | -4,010 | 89,586 | -4% | -$237,195 | |||||
| D | 2019-10-02 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $17.66 | -26,364 | 416,875 | -6% | -$465,588 | |||||
| D | 2019-10-01 | EXEL | Exelixis, Inc. | Schwab Gisela | Pres, Prod Dev, Med Aff, CMO | S - Sale+OE | $17.87 | -30,000 | 339,211 | -8% | -$536,100 | |||||
| D | 2019-10-01 | XON | Intrexon Corp | Perez Jeffrey Thomas | SVP, IP Affairs | S - Sale+OE | $5.50 | -4,521 | 52,365 | -8% | -$24,847 | |||||
| D | 2019-10-01 | XON | Intrexon Corp | Reed Thomas D. | Chief Science Officer | S - Sale+OE | $5.50 | -3,658 | 224,762 | -2% | -$20,104 | |||||
| D | 2019-10-01 | XON | Intrexon Corp | Sterling Rick L. | CFO | S - Sale+OE | $5.50 | -4,521 | 114,449 | -4% | -$24,847 | |||||
| D | 2019-10-01 | XON | Intrexon Corp | Sabzevari Helen | Pres, Precigen, Inc. | S - Sale+OE | $5.50 | -5,005 | 71,677 | -7% | -$27,507 | |||||
| D | 2019-10-01 | XON | Intrexon Corp | Bostick Thomas | COO | S - Sale+OE | $5.50 | -4,521 | 45,697 | -9% | -$24,847 | |||||
| D | 2019-10-01 | XON | Intrexon Corp | Lehr Donald P. | GC | S - Sale+OE | $5.50 | -5,001 | 66,816 | -7% | -$27,485 | |||||
| D | 2019-09-25 | NRC | National Research Corp | Jackson Steven D. | Pres | S - Sale+OE | $60.79 | -4,000 | 93,596 | -4% | -$243,156 | |||||
| D | 2019-09-20 | NRC | National Research Corp | Jackson Steven D. | Pres | S - Sale+OE | $63.20 | -2,500 | 97,596 | -2% | -$158,000 | |||||
| D | 2019-09-18 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $19.20 | -37,227 | 407,830 | -8% | -$714,758 | |||||
2019-09-19 | NRC | National Research Corp | Amandla Mk Trust | 10% | S - Sale | $63.15 | -6,200 | 6,534,273 | 0% | -$391,531 | ||||||
| D | 2019-09-19 | NRC | National Research Corp | Jackson Steven D. | Pres | S - Sale+OE | $63.50 | -380 | 100,096 | 0% | -$24,130 | |||||
| D | 2019-09-18 | INCY | Incyte Corp | Swain Paula J | EVP, HR | S - Sale+OE | $80.00 | -2,500 | 41,612 | -6% | -$200,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |